Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Upadacitinib may effectively treat resistant lichen planopilaris.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

New compounds show promise as nonsteroidal treatments for hair loss.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Finasteride increases CD8+ T cells in BPH tissues.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

El acetato de ciproterona trata problemas androgénicos como hirsutismo, acné, seborrea y alopecia con diferentes dosis y combinaciones.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.